AzTrials
AzTrials

Autism Spectrum DisorderNCT07571434

Pilot of Unstuck and On Target in Ecuador

A study testing Spanish-Language Unstuck and On Target (SL-Unstuck) in people with Autism Spectrum Disorder and Attention Deficit Disorder With Hyperactivity (ADHD), run by University of Colorado, Denver at 1 site in Ecuador.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn about the effects of the Spanish-language intervention, Unstuck and On Target (SL-Unstuck), in Spanish-speaking families in Ecuador of children 8-11 years old with attention deficit hyperactivity disorder (ADHD) or autism. Read more about this study

Who is it for?
Ages 8 to 11 years
What is being tested?
Spanish-Language Unstuck and On Target (SL-Unstuck)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEcuador
Study dates
8 Sep 2025to 18 Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 11 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • 8-11-years old
  • Meet DSM-5 criteria for Autism Spectrum Disorder and/or Attention deficit hyperactivity disorder (ADHD)
  • Verbal skills of 7-years-old or greater as measured on the WISC-V Vocabulary subtest
  • Caregiver endorsement of at least one specified executive functioning problem
  • Caregiver must be at least 18 years old
  • Caregiver must identify their preferred/primary language as Spanish

Who cannot join

  • Child does not meet criteria for age, diagnosis, verbal language skills, or parent endorsement of EF difficulties
  • Caregiver does not meet criteria or age or preferred language

Trial locations and contacts

1 site in 1 country.

Ecuador1 site
  • Neurodesarrollo Quito

    Quito, 170528

Other trials in Ecuador

About this study

Official title: Piloting Clinic-based Unstuck and On Target in Ecuador

The goal of this clinical trial is to learn about the effects of the Spanish-language intervention, Unstuck and On Target (SL-Unstuck), in Spanish-speaking families in Ecuador of children 8-11 years old with attention deficit hyperactivity disorder (ADHD) or autism. The main objectives of this study are:

  • To assess the feasibility and acceptability of SL-Unstuck in Ecuador.
  • Compare SL-Unstuck child and caregiver outcomes to waitlist controls in Ecuador.
Read more

Researchers will compare families who are randomized to receive the intervention for 8 weeks to a waitlist control for 8 weeks prior to receiving the intervention.

Participants will:

  • Complete pre- and post- intervention measures
  • Receive the Spanish-language Unstuck and On Target intervention for 8 weeks
  • Participate in focus group to gather qualitative feedback
Being tested
Spanish-Language Unstuck and On Target (SL-Unstuck)
Medical subject headings
Autism Spectrum Disorder, Attention Deficit Disorder with Hyperactivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Spanish-Language Unstuck and On Target (SL-Unstuck)Behavioural

    Unstuck and On Target teaches children the necessary skills to think flexibly and develop plans to reach their goals, while also providing the adults in their lives a framework to help support development of these skills. For this study, participants will receive weekly 90-minute sessions, over the course of 8 weeks. The child portion of the intervention will take place in parallel to 60-minute caregiver sessions.

Study groups in NCT07571434
Study groupRoleWhat they receive
UnstuckExperimentalNot described
Receives: Behavioral: Spanish-Language Unstuck and On Target (SL-Unstuck)
WaitlistNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2)

    Measured: At baseline and again at post-intervention appointment about 10 weeks later

  2. Executive Function Challenge Task (EFCT)

    Measured: At baseline and again at post-intervention appointment about 10 weeks later

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2026
  2. Study start8 Sep 2025
  3. Primary completion19 Feb 2026
  4. Study completion18 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
randomized control trial comparing immediate intervention to waitlist control
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07571434
Sponsor's protocol ID
23-2400
Status last verified
May 2026
First submitted
24 Apr 2026
Last updated
6 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Stahmer AC, Vejnoska S, Iadarola S, Straiton D, Segovia FR, Luelmo P, Morgan EH, Lee HS, Javed A, Bronstein B, Hochheimer S, Cho E, Aranbarri A, Mandell D, Hassrick EM, Smith T, Kasari C. Caregiver Voices: Cross-Cultural Input on Improving Access to Autism Services. J Racial Ethn Health Disparities. 2019 Aug;6(4):752-773. doi: 10.1007/s40615-019-00575-y. Epub 2019 Mar 11.

    PubMed 30859514
  • Anthony L, Anthony B, Kenworthy L. Improving Classroom Behaviors among Students with Symptoms of Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder [Internet]. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2020 Jun. Available from http://www.ncbi.nlm.nih.gov/books/NBK615639/

    PubMed 40554639
  • Kenworthy L, Anthony LG, Naiman DQ, Cannon L, Wills MC, Luong-Tran C, Werner MA, Alexander KC, Strang J, Bal E, Sokoloff JL, Wallace GL. Randomized controlled effectiveness trial of executive function intervention for children on the autism spectrum. J Child Psychol Psychiatry. 2014 Apr;55(4):374-83. doi: 10.1111/jcpp.12161. Epub 2013 Nov 21.

    PubMed 24256459
  • Safer-Lichtenstein J, Campos L, Smith JV, Dahlman T, Mikulich-Gilbertson S, Holmes J, Verbalis A, Ratto A, Hardy K, Armour AC, Anthony BJ, Kenworthy L, Anthony L. "In our language": Acceptability and impact of executive function videos for Spanish-speaking families. Res Autism. 2025 Oct;128:202719. doi: 10.1016/j.reia.2025.202719. Epub 2025 Oct 3.

    PubMed 41766921
  • West, E., Travers, J., Kemper, T., Liberty, L., Cote, D., McCollow, M., & Stansberry Brusnahan, L. (2016). Racial and ethnic diversity of participants in research supporting evidence-based practices for learners with autism spectrum disorder. The Journal of Special Education, 50(3), 151-163. DOI: 10.1177/0022466916632495

Questions about this trial

What is this clinical trial studying?

A study testing Spanish-Language Unstuck and On Target (SL-Unstuck) in people with Autism Spectrum Disorder and Attention Deficit Disorder With Hyperactivity (ADHD), run by University of Colorado, Denver at 1 site in Ecuador.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ecuador. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2) (time frame: At baseline and again at post-intervention appointment about 10 weeks later). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07571434, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in